Table A3.
Descriptive analysis of the study samples, stratified by jurisdiction.
| Variable | Indigenous (n = 1821) | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| NT | SA | QLD | WA | |||||||||
| n | Column Percent (C%) | Row Percent (R%) | n | C% | R% | n | C% | R% | n | C% | R% | |
| Total | 1207 | 100% | 36% | 54 | 100% | 47% | 380 | 100% | 24% | 180 | 100% | 23% |
| Most Recent Age (years) | ||||||||||||
| 3–14 | 39 | 3% | 9% | <5 | 4% | 9% | 49 | 13% | 16% | 17 | 9% | 12% |
| 15–24 | 78 | 6% | 11% | 5 | 9% | 24% | 50 | 13% | 13% | 26 | 14% | 13% |
| 25–34 | 189 | 16% | 27% | 12 | 22% | 55% | 58 | 15% | 19% | 35 | 19% | 20% |
| 35–44 | 341 | 28% | 55% | 9 | 17% | 64% | 55 | 14% | 26% | 36 | 20% | 28% |
| 45–54 | 291 | 24% | 59% | 8 | 15% | 57% | 94 | 25% | 47% | 31 | 17% | 37% |
| 55–75 | 268 | 22% | 65% | 18 | 33% | 78% | 72 | 19% | 50% | 35 | 19% | 61% |
| Sex | ||||||||||||
| Male | 427 | 35% | 33% | 20 | 37% | 50% | 154 | 41% | 25% | 52 | 29% | 19% |
| Female | 780 | 65% | 37% | 34 | 63% | 45% | 226 | 59% | 24% | 128 | 71% | 25% |
| Diagnosis | ||||||||||||
| ARF Only | 143 | 12% | 19% | 5 | 9% | 23% | 95 | 25% | 30% | 41 | 23% | 20% |
| RHD Only | 998 | 83% | 56% | 48 | 89% | 61% | 277 | 73% | 31% | 134 | 74% | 36% |
| Both | 66 | 5% | 8% | <5 | 2% | 7% | 8 | 2% | 2% | 5 | 3% | 3% |
| RHD Severity | ||||||||||||
| Severe RHD | 479 | 40% | 43% | 35 | 65% | 71% | 160 | 42% | 34% | 91 | 51% | 33% |
| Mild/ Moderate RHD | 585 | 48% | 39% | 14 | 26% | 31% | 125 | 33% | 16% | 48 | 27% | 16% |
| ARF Only | 143 | 12% | 19% | 5 | 9% | 23% | 95 | 25% | 30% | 41 | 23% | 20% |
| ARF Recurrence | ||||||||||||
| Total ARF Cases | 209 | 17% | 13% | 6 | 11% | 16% | 103 | 27% | 15% | 46 | 25% | 12% |
| No Recurrence | 170 | 81% | 14% | 5 | 83% | 14% | 99 | 96% | 17% | 39 | 85% | 12% |
| Recurrence | 39 | 19% | 12% | <5 | 17% | 100% | <5 | 4% | 5% | 7 | 15% | 9% |
| Indigenous (n = 1821) | ||||||||||||
| NT (n = 1207) | SA (n = 54) | QLD (n = 380) | WA (n = 180) | |||||||||
| Variable | n | C% | R% | n | C% | R% | n | C% | R% | n | C% | R% |
| Vital Status | ||||||||||||
| Alive | 882 | 73% | 31% | 49 | 91% | 42% | 317 | 83% | 22% | 155 | 86% | 21% |
| Dead | 325 | 27% | 62% | 5 | 9% | 71% | 63 | 17% | 66% | 25 | 14% | 56% |
| Remoteness (ARIA) | ||||||||||||
| Inner Regional | <5 | 0% | 100% | 24 | 44% | 73% | 75 | 20% | 49% | 62 | 34% | 53% |
| Outer Regional | 165 | 14% | 49% | 19 | 35% | 59% | 135 | 36% | 24% | 22 | 12% | 43% |
| Remote | 1028 | 85% | 36% | 9 | 17% | 39% | 170 | 45% | 21% | 96 | 53% | 16% |
| SES | ||||||||||||
| Quintile I & II | 124 | 10% | 48% | 18 | 33% | 95% | 59 | 16% | 34% | 44 | 24% | 32% |
| Quintile III | 111 | 9% | 51% | 7 | 13% | 54% | 137 | 36% | 27% | 27 | 15% | 51% |
| Quintile IV | 136 | 11% | 42% | 23 | 43% | 50% | 113 | 30% | 25% | 64 | 36% | 24% |
| Quintile V | 825 | 68% | 34% | <5 | 7% | 40% | 71 | 19% | 20% | 45 | 25% | 15% |
| Last Diagnosis Since Register Establishment (years) | ||||||||||||
| Mean Time | 8.3 | 2.1 | 4.0 | 2.7 | ||||||||
| 0–<2 | 93 | 8% | 74% | 19 | 35% | 59% | 69 | 18% | 24% | 57 | 32% | 37% |
| 2+ | 1114 | 92% | 34% | 35 | 65% | 42% | 311 | 82% | 24% | 123 | 68% | 20% |
| Comorbidity | ||||||||||||
| Any Comorbidity | 916 | 76% | 50% | 44 | 81% | 75% | 245 | 64% | 34% | 130 | 72% | 34% |
| Chronic Obstructive Pulmonary Diseases | 239 | 20% | 59% | 11 | 20% | 85% | 49 | 13% | 51% | 37 | 21% | 44% |
| Chronic Kidney Disease | 454 | 38% | 61% | 13 | 24% | 76% | 100 | 26% | 48% | 51 | 28% | 43% |
| Other Cardiovascular Diseases | 788 | 65% | 52% | 35 | 65% | 78% | 216 | 57% | 38% | 111 | 62% | 38% |
| Coronary Heart Diseases | 364 | 30% | 66% | 12 | 22% | 71% | 102 | 27% | 65% | 45 | 25% | 67% |
| Anticoagulant | 229 | 19% | 61% | 11 | 20% | 85% | 49 | 13% | 46% | 41 | 23% | 41% |
| Diabetes | 485 | 40% | 62% | 17 | 31% | 74% | 126 | 33% | 44% | 64 | 36% | 44% |
| Mental Health Conditions | 109 | 9% | 53% | 15 | 28% | 83% | 49 | 13% | 39% | 30 | 17% | 35% |
| Indigenous (n = 1,821) | ||||||||||||
| NT (n = 1,207) | SA (n = 54) | QLD (n = 380) | WA (n = 180) | |||||||||
| Variable | n | C% | R% | n | C% | R% | n | C% | R% | n | C% | R% |
| Complications | ||||||||||||
| Any Complication | 496 | 41% | 57% | 33 | 61% | 85% | 154 | 41% | 46% | 86 | 48% | 46% |
| Stroke | 50 | 4% | 58% | <5 | 6% | 100% | 17 | 4% | 49% | 8 | 4% | 35% |
| Heart Failure | 368 | 30% | 58% | 25 | 46% | 83% | 113 | 30% | 50% | 72 | 40% | 51% |
| Atrial Fibrillation | 278 | 23% | 56% | 19 | 35% | 83% | 94 | 25% | 43% | 55 | 31% | 47% |
| Endocarditis | 38 | 3% | 54% | <5 | 7% | 100% | 21 | 6% | 58% | 10 | 6% | 43% |
| Drug/Alcohol Abuse | ||||||||||||
| Any Substance | 834 | 69% | 49% | 40 | 74% | 74% | 244 | 64% | 34% | 122 | 68% | 30% |
| Alcohol Abuse | 463 | 38% | 54% | 23 | 43% | 72% | 107 | 28% | 38% | 56 | 31% | 28% |
| Drug Abuse | 56 | 5% | 47% | 8 | 15% | 73% | 33 | 9% | 38% | 24 | 13% | 36% |
| Tobacco Smoking | 756 | 63% | 49% | 36 | 67% | 72% | 232 | 61% | 34% | 116 | 64% | 30% |
| Pregnancy | ||||||||||||
| Females of Reproductive Age | 507 | 42% | 34% | 24 | 44% | 51% | 133 | 35% | 21% | 83 | 46% | 24% |
| Pregnancy | 234 | 46% | 39% | 10 | 42% | 67% | 57 | 43% | 25% | 31 | 37% | 27% |